Blanket Purchase Agreement 36F79720D0016-36C24921A0004

The Department of Veterans Affairs Veterans Health Administration awarded a blanket purchase agreement to Polymedco LLC for fecal occult blood laboratory testing services across multiple Veterans Integrated Service Networks. The single award, firm-fixed price contract against Polymedco's Critical Analyzers, Laboratory GSA schedule has a potential value of $1,354,024.15 and period of performance from October 2020 through September 2025. The agreement facilitates colorectal cancer screening for veterans through task order calls by VISN 9 and VISN 12 valued at approximately $309,494.34, $512,005.28, $148,869.97, and $120,844.05 respectively, with testing to be performed by Polymedco at its Cortlandt Manor, New York location. The purpose of the contracted laboratory services is to support the healthcare mission of the VA by enabling facilities within the VISNs to efficiently order and receive fecal occult blood testing, which screens for signs of gastrointestinal cancers or other disorders, from a qualified provider.

The blanket purchase agreement was awarded on a single award basis using Polymedco's existing GSA Critical Analyzers, Laboratory schedule. No set-aside provisions were applied to the agreement or subsequent task order calls. Polymedco will deliver the contracted fecal occult blood laboratory testing from its New York location to multiple VA medical centers within VISN 9 and VISN 12 through September 2025. The agreement establishes an efficient means for the VA facilities to access these important cancer screening services while leveraging competitive pricing under Polymedco's established GSA schedule.